| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Cardiology and Cardiovascular Medicine | 364 / 409 | 11th | Q4 |
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Vascular Diseases (France)
Vascular Diseases (France) is Scopus-indexed (Q4, CiteScore 0.5). Published by Elsevier Masson s.r.l..
Checked against the index lists dated .
ISSN 3050-6581Verify ISSN ↗3050-659XVerify ISSN ↗
Publisher: Elsevier Masson s.r.l.
Cost to publish: About US$2,660 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is Vascular Diseases (France) indexed in Scopus?
Yes — actively indexed in Scopus, coverage 2025–present, best quartile Q4, CiteScore 0.5.
What quartile is Vascular Diseases (France) in Scopus?
Vascular Diseases (France) is Q4 in Cardiology and Cardiovascular Medicine (rank 364 of 409), by CiteScore 2025.
What is the impact factor of Vascular Diseases (France)?
Vascular Diseases (France) is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 0.5, quartile Q4, 11th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric.
How much does it cost to publish in Vascular Diseases (France)?
The publisher lists an article processing charge of about US$2,660 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Who publishes Vascular Diseases (France) and what is its ISSN?
Vascular Diseases (France) is published by Elsevier Masson s.r.l. Its print ISSN is 3050-6581 and its online ISSN is 3050-659X.
Is Vascular Diseases (France) in Web of Science?
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Is Vascular Diseases (France) open access?
No — it is not registered as an open-access journal in DOAJ or Scopus.
How well cited is Vascular Diseases (France)? — open metrics via OpenAlex
Vascular Diseases (France) has an h-index of 2 and a 2-year mean of 0.07 citations per paper (OpenAlex). Its Scopus CiteScore is 0.5, quartile Q4. On 2-year citations it ranks #378 of 398 Scopus journals in Cardiology and Cardiovascular Medicine.
Vascular Diseases (France) published 154 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Who publishes in Vascular Diseases (France)? — latest 67 articles, 2026
In its latest 67 research articles (2026), authors are most often from France (88.8%), United States (3%) and Ireland (1.5%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Are there integrity warnings for Vascular Diseases (France)? — indicators, not proof of misconduct
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusActive
- Retracted papers None recorded
- Problematic Paper Screener flags None flagged
- Author concentration88.8% of recent authorship from France
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
Related journals
8 journalsIndex data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.